Quantum Biopharma (QNTM) Other Operating Expenses (2019 - 2026)

Quantum Biopharma (QNTM) has 8 years of Other Operating Expenses data on file, last reported at $1.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 142.18% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (up 295.75% YoY), and the FY2025 full-year result was $3.5 million, up 443.15% from the prior year.
• Other Operating Expenses grew to $1.0 million in Q1 2026, from $937823.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $4.8 million in Q1 2023 to a low of $177884.0 in Q1 2024.
• A 5-year average of $1.2 million and a median of $964395.0 in 2025 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses slumped 96.31% in 2024 and soared 512.94% in 2025, its largest moves.
• Tracing QNTM's Other Operating Expenses over 5 years: stood at $1.2 million in 2022, then surged by 176.86% to $3.3 million in 2023, then tumbled by 94.57% to $177884.0 in 2024, then surged by 427.21% to $937823.0 in 2025, then advanced by 8.71% to $1.0 million in 2026.
• Business Quant data shows QNTM's Other Operating Expenses at $1.0 million in Q1 2026, $937823.0 in Q4 2025, and $1.1 million in Q3 2025.